Orphapacket:
  AverageAgeOfDeaths:
    AverageAgeOfDeath:
    - value: adult
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: Adult
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '617892'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '614808'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '615426'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '615515'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '616208'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '616437'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
      Reference: '105400'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '205250'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '300857'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '606070'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '606640'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '619133'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '608030'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '608031'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '608627'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '611895'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '612069'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '612577'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '613435'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '613954'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '600795'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '617839'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '619141'
      Source: OMIM
  Genes:
  - Gene:
      ExternalReferences: []
      Name: cyclin F
      Symbol: CCNF
  - Gene:
      ExternalReferences: []
      Name: TATA-box binding protein associated factor 15
      Symbol: TAF15
  - Gene:
      ExternalReferences: []
      Name: EPH receptor A4
      Symbol: EPHA4
  - Gene:
      ExternalReferences: []
      Name: annexin A11
      Symbol: ANXA11
  - Gene:
      ExternalReferences: []
      Name: cilia and flagella associated protein 410
      Symbol: CFAP410
  - Gene:
      ExternalReferences: []
      Name: GLE1 RNA export mediator
      Symbol: GLE1
  - Gene:
      ExternalReferences: []
      Name: NIMA related kinase 1
      Symbol: NEK1
  - Gene:
      ExternalReferences: []
      Name: glycosyltransferase 8 domain containing 1
      Symbol: GLT8D1
  - Gene:
      ExternalReferences: []
      Name: coiled-coil-helix-coiled-coil-helix domain containing 10
      Symbol: CHCHD10
  - Gene:
      ExternalReferences: []
      Name: D-amino acid oxidase
      Symbol: DAO
  - Gene:
      ExternalReferences: []
      Name: ataxin 2
      Symbol: ATXN2
  - Gene:
      ExternalReferences: []
      Name: charged multivesicular body protein 2B
      Symbol: CHMP2B
  - Gene:
      ExternalReferences: []
      Name: superoxide dismutase 1
      Symbol: SOD1
  - Gene:
      ExternalReferences: []
      Name: triggering receptor expressed on myeloid cells 2
      Symbol: TREM2
  - Gene:
      ExternalReferences: []
      Name: VAMP associated protein B and C
      Symbol: VAPB
  - Gene:
      ExternalReferences: []
      Name: valosin containing protein
      Symbol: VCP
  - Gene:
      ExternalReferences: []
      Name: neurofilament heavy chain
      Symbol: NEFH
  - Gene:
      ExternalReferences: []
      Name: optineurin
      Symbol: OPTN
  - Gene:
      ExternalReferences: []
      Name: dynactin subunit 1
      Symbol: DCTN1
  - Gene:
      ExternalReferences: []
      Name: TAR DNA binding protein
      Symbol: TARDBP
  - Gene:
      ExternalReferences: []
      Name: FIG4 phosphoinositide 5-phosphatase
      Symbol: FIG4
  - Gene:
      ExternalReferences: []
      Name: FUS RNA binding protein
      Symbol: FUS
  - Gene:
      ExternalReferences: []
      Name: angiogenin
      Symbol: ANG
  - Gene:
      ExternalReferences: []
      Name: matrin 3
      Symbol: MATR3
  - Gene:
      ExternalReferences: []
      Name: peripherin
      Symbol: PRPH
  - Gene:
      ExternalReferences: []
      Name: paraoxonase 1
      Symbol: PON1
  - Gene:
      ExternalReferences: []
      Name: paraoxonase 2
      Symbol: PON2
  - Gene:
      ExternalReferences: []
      Name: paraoxonase 3
      Symbol: PON3
  - Gene:
      ExternalReferences: []
      Name: sequestosome 1
      Symbol: SQSTM1
  - Gene:
      ExternalReferences: []
      Name: ubiquilin 2
      Symbol: UBQLN2
  - Gene:
      ExternalReferences: []
      Name: C9orf72-SMCR8 complex subunit
      Symbol: C9ORF72
  - Gene:
      ExternalReferences: []
      Name: profilin 1
      Symbol: PFN1
  - Gene:
      ExternalReferences: []
      Name: TANK binding kinase 1
      Symbol: TBK1
  - Gene:
      ExternalReferences: []
      Name: heterogeneous nuclear ribonucleoprotein A1
      Symbol: HNRNPA1
  - Gene:
      ExternalReferences: []
      Name: PPARG coactivator 1 alpha
      Symbol: PPARGC1A
  - Gene:
      ExternalReferences: []
      Name: erb-b2 receptor tyrosine kinase 4
      Symbol: ERBB4
  - Gene:
      ExternalReferences: []
      Name: unc-13 homolog A
      Symbol: UNC13A
  Label: Amyotrophic lateral sclerosis
  ORPHAcode: '803'
  ORPHApacketId: '803'
  PURL: http://www.orpha.net/ORDO/Orphanet_803
  Parents:
  - Parent:
    - Label: Motor neuron disease
      ORPHAcode: '98503'
  - Parent:
    - Label: Rare neurodegenerative disease
      ORPHAcode: '182070'
  - Parent:
    - Label: Genetic neurodegenerative disease
      ORPHAcode: '183500'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Obligate (100%)
      HPOId: HP:0007354
      HPOTerm: Amyotrophic lateral sclerosis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002180
      HPOTerm: Neurodegeneration
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003324
      HPOTerm: Generalized muscle weakness
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0007373
      HPOTerm: Motor neuron atrophy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000217
      HPOTerm: Xerostomia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000712
      HPOTerm: Emotional lability
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000716
      HPOTerm: Depression
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000739
      HPOTerm: Anxiety
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001257
      HPOTerm: Spasticity
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002094
      HPOTerm: Dyspnea
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002795
      HPOTerm: Functional respiratory abnormality
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002878
      HPOTerm: Respiratory failure
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003202
      HPOTerm: Skeletal muscle atrophy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003394
      HPOTerm: Muscle spasm
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003470
      HPOTerm: Paralysis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012378
      HPOTerm: Fatigue
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012531
      HPOTerm: Pain
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0030192
      HPOTerm: Fatigable weakness of bulbar muscles
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0030195
      HPOTerm: Fatigable weakness of swallowing muscles
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0030196
      HPOTerm: Fatigable weakness of respiratory muscles
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000713
      HPOTerm: Agitation
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002017
      HPOTerm: Nausea and vomiting
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0025425
      HPOTerm: Laryngospasm
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 19710046[PMID]_[EXPERT]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19192301[PMID]_[EXPERT]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21665992[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 21665992[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 17898523[PMID]_17219036[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 17898523[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 10025778[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 10025778[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 6601351[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 6601351[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Canada
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 3762972[PMID]_19494548[PMID]_ ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Canada
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 3762972[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 25298019[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Uruguay
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 18334826[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Uruguay
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 18334826[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Denmark
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 2786160[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Denmark
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 2786160[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 19237701[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19237701[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: France
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 19452307[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 23286747[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 23286747[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 21860251[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21860251[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Taiwan, Province of China
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: DOI:10.1016/j.jfma.2013.01.008[OTHER]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Taiwan, Province of China
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: DOI:10.1016/j.jfma.2013.01.008[OTHER]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Faroe Islands
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 22034926[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Iran, Islamic Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 20214678[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Iran, Islamic Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 20214678[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Specific population
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 23052600[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Specific population
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 23052600[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Specific population
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 22409362[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Specific population
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 22409362[PMID]
      ValMoy: no data
  Synonyms:
  - Synonym: ALS
  - Synonym: Charcot disease
  - Synonym: Lou Gehrig disease
  TextSection:
    Contents: A neurodegenerative disease characterized by progressive muscular paralysis
      reflecting degeneration of motor neurons in the primary motor cortex corticospinal
      tracts brainstem and spinal cord.
    TextSectionType: Definition
  TypeOfInheritances:
  - TypeOfInheritance:
      value: Autosomal dominant
  - TypeOfInheritance:
      value: Autosomal recessive
  - TypeOfInheritance:
      value: Not applicable
  copyright: Orphanet (c) 2022
  creationDate: '2022-11-28 11:04:13'
  version: 1.3.18 / 4.1.7 [2022-07-12] (orientdb version)
